DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents.

In rats, DPI-3290 (i.v; 0.05 mg/kg) produces a 50% antinociceptive response.

182417-73-8

C30H34FN3O2

487.61

Org 41793;DPI-3290

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years